ArticleCurrent treatment options in gastroenterology2004
Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment.
Article in Current treatment options in gastroenterology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01324895 (Retrospective Analysis of Treatment Outcomes in Patients With Bacterial Overgrowth Syndrome Diagnosed by D-Xylose Breath Testing), which is not on this map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Retrospective Analysis of Treatment Outcomes in Patients With Bacterial Overgrowth Syndrome Diagnosed by D-Xylose Breath Testing
Who cites it
25 citing papers in PubMed.
- Small Intestinal Bacterial Overgrowth in Children with Short Bowel Syndrome: Risk Factors, Clinical Presentation and Management-A Single-Center Experience.Children (Basel, Switzerland) · 2025Article
- Article
- Bowel-associated dermatosis-arthritis syndrome (BADAS): a narrative review.Postepy dermatologii i alergologii · 2023Review
- Small Intestinal Bacterial Overgrowth in Children: Clinical Features and Treatment Response.JPGN reports · 2022Article
- D-lactic acidosis presenting as metabolic encephalopathy in a patient with short bowel syndrome.BMJ case reports · 2021Article
- Medical Management of Chronic Pancreatitis in Children: A Position Paper by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Pancreas Committee.Journal of pediatric gastroenterology and nutrition · 2021Article
- Small intestinal bacterial overgrowth as a cause of protracted wound healing and vitamin D deficiency in a spinal cord injured patient with a sacral pressure sore: a case report.BMC gastroenterology · 2020Article
- The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders.International journal of molecular sciences · 2020Review
- Small Intestinal Bacterial Overgrowth Is Common in Chronic Pancreatitis and Associates With Diabetes, Chronic Pancreatitis Severity, Low Zinc Levels, and Opiate Use.The American journal of gastroenterology · 2019Article
- Uncommon Diverticular Disease.Clinics in colon and rectal surgery · 2018Review
- Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.Gut and liver · 2017Review
- Irritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and Metabolic Syndrome.Yonsei medical journal · 2016Article
- Review
- Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives.World journal of gastroenterology · 2014Review
- Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance.Therapeutic advances in chronic disease · 2013Article
- Jejunal diverticulosis.Annals of gastroenterology · 2013Article
- Diarrhoea due to small bowel diseases.Best practice & research. Clinical gastroenterology · 2012Review
- Antibiotics for the treatment of irritable bowel syndrome.Gastroenterology & hepatology · 2011Article
- Functional abdominal pain and irritable bowel syndrome in children and adolescents.Therapy (London, England : 2004) · 2011Article
- Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?BMC gastroenterology · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Small bowel bacterial overgrowth (SBBO) syndrome is associated with excessive numbers of bacteria in the proximal small intestine. The pathology of this condition involves competition between the bacteria and the human host for ingested nutrients. This competition leads to intraluminal bacterial catabolism of nutrients, often with production of toxic metabolites and injury to the enterocyte. A complex array of clinical symptoms ensues, resulting in chronic diarrhea, steatorrhea, macrocytic anemia, weight loss, and less commonly, protein-losing enteropathy. Therapy is targeted at correction of underlying small bowel abnormalities that predispose to SBBO and appropriate antibiotic therapy. The symptoms and signs of SBBO can be reversed with this approach.
Identifiers
14723835What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.